agilon health, inc. (NYSE:AGL) Shares Acquired by EntryPoint Capital LLC

EntryPoint Capital LLC lifted its position in agilon health, inc. (NYSE:AGL) by 275.8% in the fourth quarter, Holdings Channel reports. The firm owned 233,069 shares of the company’s stock after acquiring an additional 171,052 shares during the period. EntryPoint Capital LLC’s holdings in agilon health were worth $443,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in AGL. Citigroup Inc. lifted its stake in agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after buying an additional 1,941,993 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of agilon health by 49.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company’s stock valued at $8,629,000 after acquiring an additional 1,498,524 shares during the period. JPMorgan Chase & Co. raised its position in agilon health by 326.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after purchasing an additional 1,083,492 shares during the last quarter. Alberta Investment Management Corp acquired a new stake in agilon health during the 4th quarter worth $1,564,000. Finally, Quantbot Technologies LP purchased a new position in agilon health during the 3rd quarter worth $1,742,000.

Wall Street Analyst Weigh In

AGL has been the subject of a number of research reports. Sanford C. Bernstein upped their target price on shares of agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a report on Wednesday, January 15th. Citigroup raised agilon health from a “sell” rating to a “neutral” rating and upped their price objective for the company from $1.75 to $2.25 in a research note on Friday, January 10th. Royal Bank of Canada lifted their target price on agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a research note on Wednesday, February 26th. Stifel Nicolaus upped their price target on agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a research note on Wednesday, February 26th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of agilon health in a research report on Friday, March 21st. Two analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat, agilon health presently has a consensus rating of “Hold” and a consensus target price of $3.95.

agilon health Stock Down 0.2 %

Shares of NYSE AGL opened at $4.47 on Wednesday. The stock has a market capitalization of $1.84 billion, a price-to-earnings ratio of -4.76 and a beta of 0.67. agilon health, inc. has a 52 week low of $1.50 and a 52 week high of $7.73. The firm has a 50-day moving average price of $3.58 and a 200 day moving average price of $2.95. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.